Nrf2/HO-1 Axis Regulates the Angiogenesis of Gastric Cancer via Targeting VEGF

References

• Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–1953. doi:10.1002/ijc.3193730350310
   PubMed Web of Science ®Google Scholar
• Moi P, Chan K, Asunis I, Cao A, Kan YW. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc Natl Acad Sci U S A. 1994;91(21):9926–9930. doi:10.1073/pnas.91.21.99267937919
   PubMed Web of Science ®Google Scholar
• Tebay LE, Robertson H, Durant ST, et al. Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease. Free Radic Biol Med. 2015;88(PtB):108–146. doi:10.1016/j.freeradbiomed.2015.06.02126122708
   PubMed Web of Science ®Google Scholar
• Na HK, Surh YJ. Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1. Free Radic Biol Med. 2014;67:353–365. doi:10.1016/j.freeradbiomed.2013.10.81924200599
   PubMed Web of Science ®Google Scholar
• Chiang SK, Chen SE, Chang LC. A dual role of heme oxygenase-1 in cancer cells. Int J Mol Sci. 2018;20(1):39. doi:10.3390/ijms20010039
   PubMed Web of Science ®Google Scholar
• Nitti M, Piras S, Marinari UM, Moretta L, Pronzato MA, Furfaro AL. HO-1 induction in cancer progression: a matter of cell adaptation. Antioxidants (Basel). 2017;6(2). doi:10.3390/antiox6020029
   PubMedGoogle Scholar
• Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol. 2007;47(1):89–116. doi:10.1146/annurev.pharmtox.46.120604.14104616968214
   PubMed Web of Science ®Google Scholar
• Lau A, Villeneuve NF, Sun Z, Wong PK, Zhang DD. Dual roles of Nrf2 in cancer. Pharmacol Res. 2008;58(5–6):262–270. doi:10.1016/j.phrs.2008.09.00318838122
   PubMed Web of Science ®Google Scholar
• Deng Y, Wu Y, Zhao P, et al. The Nrf2/HO-1 axis can be a prognostic factor in clear cell renal cell carcinoma. Cancer Manag Res. 2019;11:1221–1230. doi:10.2147/CMAR.S18804630799949
   PubMed Web of Science ®Google Scholar
• Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D. Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Radiother Oncol. 2014;110(1):189–194. doi:10.1016/j.radonc.2013.09.01524636158
   PubMed Web of Science ®Google Scholar
• Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis–correlation in invasive breast carcinoma. N Engl J Med. 1991;324(1):1–8. doi:10.1056/NEJM199101033240101
   PubMed Web of Science ®Google Scholar
• Wang M, Shi G, Bian C, et al. UVA irradiation enhances brusatol-mediated inhibition of melanoma growth by downregulation of the Nrf2-mediated antioxidant response. Oxid Med Cell Longev. 2018;2018:9742154. doi:10.1155/2018/974215429670684
   PubMed Web of Science ®Google Scholar
• Wang C, Luo Z, Carter G, et al. NRF2 prevents hypertension, increased ADMA, microvascular oxidative stress, and dysfunction in mice with two weeks of ANG II infusion. Am J Physiol Regul Integr Comp Physiol. 2018;314(3):R399–R406. doi:10.1152/ajpregu.00122.201729167164
   PubMed Web of Science ®Google Scholar
• Xu W, Yang Z, Lu N. Molecular targeted therapy for the treatment of gastric cancer. J Exp Clin Cancer Res. 2016;35(1):1. doi:10.1186/s13046-015-0276-926728266
   PubMed Web of Science ®Google Scholar
• Melincovici CS, Bosca AB, Susman S, et al. Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis. Rom J Morphol Embryol. 2018;59(2):455–467.30173249
   PubMed Web of Science ®Google Scholar
• Ramakrishnan S, Anand V, Roy S. Vascular endothelial growth factor signaling in hypoxia and inflammation. J Neuroimmune Pharmacol. 2014;9(2):142–160. doi:10.1007/s11481-014-9531-724610033
   PubMed Web of Science ®Google Scholar
• Shibuya M. Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. J Biochem. 2013;153(1):13–19. doi:10.1093/jb/mvs13623172303
   PubMed Web of Science ®Google Scholar
• Goel HL, Mercurio AM. VEGF targets the tumour cell. Nat Rev Cancer. 2013;13(12):871–882. doi:10.1038/nrc362724263190
   PubMed Web of Science ®Google Scholar
• Bell EL, Klimova TA, Eisenbart J, Schumacker PT, Chandel NS. Mitochondrial reactive oxygen species trigger hypoxia-inducible factor-dependent extension of the replicative life span during hypoxia. Mol Cell Biol. 2007;27(16):5737–5745. doi:10.1128/MCB.02265-0617562866
   PubMed Web of Science ®Google Scholar
• Kolamunne RT, Dias IH, Vernallis AB, Grant MM, Griffiths HR. Nrf2 activation supports cell survival during hypoxia and hypoxia/reoxygenation in cardiomyoblasts; the roles of reactive oxygen and nitrogen species. Redox Biol. 2013;1(1):418–426. doi:10.1016/j.redox.2013.08.00224191235
   PubMed Web of Science ®Google Scholar
• Yang YY, Wang WJ, Wang XF, et al. Inhibitory effect of dextran sulfate on proliferation, migration and expression of related factors in human gastric cancer cells. J Pract Med. 2019;35(07):1057–1063. (In Chinese).
   Google Scholar
• Kim TH, Hur EG, Kang SJ, et al. NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1alpha. Cancer Res. 2011;71(6):2260–2275. doi:10.1158/0008-5472.CAN-10-300721278237
   PubMed Web of Science ®Google Scholar
• Ji X, Wang H, Zhu J, et al. Knockdown of Nrf2 suppresses glioblastoma angiogenesis by inhibiting hypoxia-induced activation of HIF-1alpha. Int J Cancer. 2014;135(3):574–584. doi:10.1002/ijc.2869924374745
   PubMed Web of Science ®Google Scholar
• Kozakowska M, Dobrowolska-Glazar B, Okon K, Jozkowicz A, Dobrowolski Z, Dulak J. Preliminary analysis of the expression of selected proangiogenic and antioxidant genes and MicroRNAs in patients with non-muscle-invasive bladder cancer. J Clin Med. 2016;5(3):29. doi:10.3390/jcm5030029
   PubMed Web of Science ®Google Scholar
• Espada S, Ortega F, Molina-Jijon E, et al. The purinergic P2Y(13) receptor activates the Nrf2/HO-1 axis and protects against oxidative stress-induced neuronal death. Free Radic Biol Med. 2010;49(3):416–426. doi:10.1016/j.freeradbiomed.2010.04.03120447456
   PubMed Web of Science ®Google Scholar
• Kim YM, Pae HO, Park JE, et al. Heme oxygenase in the regulation of vascular biology: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal. 2011;14(1):137–167. doi:10.1089/ars.2010.315320624029
   PubMed Web of Science ®Google Scholar
• Dulak J, Jozkowicz A, Foresti R, et al. Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells. Antioxid Redox Signal. 2002;4(2):229–240. doi:10.1089/15230860275366628012006174
   PubMed Web of Science ®Google Scholar
• Jozkowicz A, Huk I, Nigisch A, Weigel G, Weidinger F, Dulak J. Effect of prostaglandin-J(2) on VEGF synthesis depends on the induction of heme oxygenase-1. Antioxid Redox Signal. 2002;4(4):577–585. doi:10.1089/1523086026022007612230869
   PubMed Web of Science ®Google Scholar
• Miyake M, Fujimoto K, Anai S, et al. Heme oxygenase-1 promotes angiogenesis in urothelial carcinoma of the urinary bladder. Oncol Rep. 2011;25(3):653–660. doi:10.3892/or.2010.112521206978
   PubMed Web of Science ®Google Scholar
• Sunamura M, Duda DG, Ghattas MH, et al. Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer. Angiogenesis. 2003;6(1):15–24. doi:10.1023/a:102580360084014517400
   PubMedGoogle Scholar
• Shang FT, Hui LL, An XS, Zhang XC, Guo SG, Kui Z. ZnPPIX inhibits peritoneal metastasis of gastric cancer via its antiangiogenic activity. Biomed Pharmacother. 2015;71:240–246. doi:10.1016/j.biopha.2015.03.00525960243
   PubMed Web of Science ®Google Scholar